Add to ORKGObjective: To determine, “Is clofibrate a safe and effective adjunctive treatment to phototherapy for neonatal jaundice?
Background: Aximately 60% of normal birth infant become jaundiced in the first week of birth. The in...
Introduction: Jaundice is observed during the 1st week after birth in approximately 60% of term infa...
Background: Aximately 60% of normal birth infant become jaundiced in the first week of birth. The in...
Objective: To determine, “Is clofibrate a safe and effective adjunctive treatment to phototherapy fo...
Objective: To determine, “Is clofibrate a safe and effective adjunctive treatment to phototherapy fo...
Objective: Clofibrate has been used for several years as a hypolipidemic drug. Our aim was to study...
Objective: Clofibrate has been used for several years as a hypolipidemic drug. Our aim was to study...
Objective: this study was designed to determine the effect of clofibrate on neonatal uncomplicated ...
Background : Despite an understanding of the enzymatic pathways leading to bilirubin production and ...
Background: Neonatal jaundice is a prevalent disease that causes many complications, including kerni...
Background: Neonatal jaundice is a common problem that can result in serious neurological side effec...
BACKGROUND AND OBJECTIVE: Jaundice (hyperbilirubinemia) is one of the most common clinical complain...
Objective: Neonatal jaundice is one of the most common findings in examination of neonates. Photothe...
Background: Aximately 60% of normal birth infant become jaundiced in the first week of birth. The in...
Background: Aximately 60% of normal birth infant become jaundiced in the first week of birth. The in...
Background: Aximately 60% of normal birth infant become jaundiced in the first week of birth. The in...
Introduction: Jaundice is observed during the 1st week after birth in approximately 60% of term infa...
Background: Aximately 60% of normal birth infant become jaundiced in the first week of birth. The in...
Objective: To determine, “Is clofibrate a safe and effective adjunctive treatment to phototherapy fo...
Objective: To determine, “Is clofibrate a safe and effective adjunctive treatment to phototherapy fo...
Objective: Clofibrate has been used for several years as a hypolipidemic drug. Our aim was to study...
Objective: Clofibrate has been used for several years as a hypolipidemic drug. Our aim was to study...
Objective: this study was designed to determine the effect of clofibrate on neonatal uncomplicated ...
Background : Despite an understanding of the enzymatic pathways leading to bilirubin production and ...
Background: Neonatal jaundice is a prevalent disease that causes many complications, including kerni...
Background: Neonatal jaundice is a common problem that can result in serious neurological side effec...
BACKGROUND AND OBJECTIVE: Jaundice (hyperbilirubinemia) is one of the most common clinical complain...
Objective: Neonatal jaundice is one of the most common findings in examination of neonates. Photothe...
Background: Aximately 60% of normal birth infant become jaundiced in the first week of birth. The in...
Background: Aximately 60% of normal birth infant become jaundiced in the first week of birth. The in...
Background: Aximately 60% of normal birth infant become jaundiced in the first week of birth. The in...
Introduction: Jaundice is observed during the 1st week after birth in approximately 60% of term infa...
Background: Aximately 60% of normal birth infant become jaundiced in the first week of birth. The in...